CheckMyRecalls

RemedyRepack Inc. recalls Carvedilol 25 mg Tablet

Published
12 Feb 2025
Units affected
247 blister packs
Agency
FDA
Country
United States

The hazard

CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.

Brand / company
RemedyRepack Inc.
Codes / lots
Lot #s: J0777493050824, Exp. 5/31/2025; J0787856062124, Exp. 7/31/2025.
Distribution
FL
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 12 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.